Neuropharmacology of the essential oil of bergamot |
| |
Authors: | Giacinto Bagetta,Luigi Antonio Morrone,Laura Rombolà ,Diana Amantea,Rossella Russo,Laura Berliocchi,Shinobu Sakurada,Tsukasa Sakurada,Domenicantonio Rotiroti,Maria Tiziana Corasaniti |
| |
Affiliation: | 1. Department of Pharmacobiology and University Centre for Adaptive Disorders and Headache (UCADH), Section of Neuropharmacology of Normal and Pathological Neuronal Plasticity, University of Calabria, Arcavacata di Rende (CS) Italy;2. Department of Pharmacobiological Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy;3. Department of Physiology and Anatomy, Tohoku Pharmaceutical University, Sendai, Japan;4. First Department of Pharmacology, Daiichi College of Pharmaceutical Sciences, Fukuoka, Japan |
| |
Abstract: | Bergamot (Citrus bergamia, Risso) is a fruit most knowledgeable for its essential oil (BEO) used in aromatherapy to minimize symptoms of stress-induced anxiety and mild mood disorders and cancer pain though the rational basis for such applications awaits to be discovered. The behavioural and EEG spectrum power effects of BEO correlate well with its exocytotic and carrier-mediated release of discrete amino acids endowed with neurotransmitter function in the mammalian hippocampus supporting the deduction that BEO is able to interfere with normal and pathological synaptic plasticity. The observed neuroprotection in the course of experimental brain ischemia and pain does support this view. In conclusion, the data yielded so far contribute to our understanding of the mode of action of this phytocomplex on nerve tissue under normal and pathological experimental conditions and provide a rational basis for the practical use of BEO in complementary medicine. The opening of a wide venue for future research and translation into clinical settings is also envisaged. |
| |
Keywords: | Essential oil of bergamot (BEO) EEG spectrum power Neurotransmitter release Brain ischemia (MCAO) Akt GSK-3β Pain |
本文献已被 ScienceDirect 等数据库收录! |
|